Phase I study of the investigational, oral pan-RAF kinase inhibitor TAK-580 (MLN2480) in patients with advanced solid tumors (ST) or melanoma (MEL): Final analysis
Autor: | M. Kneissl, Paul Lorigan, Mark R. Middleton, B Bahamon, Adil Daud, Ruth Plummer, S Skaria, E Hoberman, Pippa Corrie, Anna C. Pavlick, S. Zhang, Drew W. Rasco, L. Rangachari, Anthony J. Olszanski, Sanjiv S. Agarwala, Ricardo J. Gonzalez, M. E. Gore, C. Herbert |
---|---|
Rok vydání: | 2017 |
Předmět: | |
Zdroj: | Annals of Oncology. 28:v136-v137 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |